Updates in Hair Disorders in Cancer Patients and Survivors

This session discusses the various hair disorders encountered by cancer patients and survivors, emphasizing the significant impact of chemotherapy-induced alopecia (CIA) and persistent CIA (PCIA). Current estimates suggest that approximately 30% of cancer survivors experience some form of hair condition, highlighting the need for better management strategies. The presentation outlines the challenges of treating breast cancer and acknowledges that many patients may refuse chemotherapy due to the fear of hair loss. Scalp cooling systems have emerged as a preventive measure, showing up to a 60% success rate in preserving hair during chemotherapy. Financial support options for these treatments are discussed, including CPT codes and philanthropic organizations. For those who experience PCIA, the importance of distinguishing it from other types of hair loss, such as androgeneric alopecia, is stressed. Treatment options include minoxidil, with caution advised for patients who have received cardiotoxic chemotherapy. The session also touches upon hair loss associated with targeted therapies and immunotherapies, underscoring the importance of recognizing and managing these conditions. The talk concludes by reminding healthcare providers to address hair loss proactively, as effective management can significantly enhance patients' quality of life.